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P rimary care providers routinely see patients who are at risk for, or are affected by, common complex diseases, 
such as coronary artery disease, cancer, and diabetes [1-5]. 
Family health history is one of the strongest predictors of 
the patient’s risk for common complex diseases, and collect-
ing this information can dramatically improve identification 
of at-risk individuals [4]. For example, having 1 first-degree 
relative with breast cancer results in a woman’s risk for the 
disease being 1.8 times higher, and having 2 first-degree 
relatives nearly triples her risk [6]. Overall, 82% of primary 
care patients have a familial risk for at least 1 common dis-
ease—coronary artery disease, stroke, diabetes, breast can-
cer, colon cancer, or ovarian cancer [5, 7, 8]—and that risk 
alters the prevention recommendations for the patient. For 
instance, 15%–20% of patients meet family health history 
criteria for beginning colonoscopy screenings before age 
50 years [9].
Because primary care providers are frequently a patient’s 
first point of contact with the health care system, they are 
well positioned to identify patients who are at increased 
risk for disease and to implement appropriate prevention 
strategies in order to lower risk or detect disease earlier [2]. 
Professional [10-12] and evidence-based [13] guidelines are 
widely available; these guidelines can be used to collect fam-
ily health histories for common diseases, such as colon can-
cer [14-17], breast cancer [17-20], heart disease [12], and 
diabetes [21, 22]. Such guidelines have been endorsed by 
primary care organizations [10, 23, 24], yet they are unde-
rutilized in primary care settings [25-27]. Barriers to their 
use include the time required to collect an accurate family 
health history, the need to balance the patient’s agenda with 
the physician’s goals, the difficulty of finding information 
about family health history within the chart, and the lack of 
procedures for quickly collecting and analyzing family health 
history data [2, 28-31]. Using patient-collected information 
about family health history and incorporating it into the 
electronic medical record (EMR) might help to overcome 
these barriers [32, 33].
Making recommendations based on familial risk requires 
an accurate and detailed family health history [26]. Key 
elements of such a history are that it covers 3 generations 
(grandparents; parents, aunts, and uncles; and half siblings 
and full siblings) and that it includes age of disease onset, 
relationship to the patient, and age and cause of death (if 
deceased) for each individual [29, 34-36]. It is also impor-
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tant that the family health history make note of common 
diseases that are not found in the family (a negative, or 
“unremarkable,” family history) [34]. Although most pri-
mary care providers collect a family health history, the docu-
mented elements vary [25, 26, 31].
The primary goal of this study was to assess the com-
pleteness of family health history data in the medical charts 
of primary care providers and to evaluate the utility of these 
data for providing patient risk assessments. The chart 
review was performed in selected primary care practices in 
a midsized community in the Southern United States.
Methods
Paper and EMR charts were reviewed in 1 internal 
medicine and 2 internal medicine/family medicine com-
munity-based practices serving patients with a range of 
socioeconomic and insurance statuses. The size of the 
practices ranged from 4 providers seeing 1,700 patients per 
month to 9 providers seeing 4,000 patients per month.
Data instrument. Our chart review checklist consists of 32 
questions (including 14 multiple-choice questions, 9 dichoto-
mous [yes/no] questions, and 9 fill-in-the-blank questions) 
and a chart on which the reviewer can circle whether par-
ticular types of information are “always,” “sometimes,” or 
“never” documented for various relatives. (See Appendix 1; 
online version only). The checklist is divided into sections 
dealing with the patient’s demographics and personal health 
history, the patient’s insurance, date(s) of personal and fam-
ily health history collection, family health history data, and 
specialty referrals based on family health history. Fifteen 
of the questions on our checklist (marked with an asterisk) 
were adapted from the 2006 chart audit tool developed by 
the Michigan Department of Community Health’s genomics 
team (D. Duquette, unpublished observations, 2012). Our 
checklist was piloted and modified to ensure that all of the 
necessary information would be obtained.
The checklist and methodology were approved by 
the institutional review boards of the University of North 
Carolina at Greensboro, Moses H. Cone Memorial Hospital, 
and the US Army Medical Research and Materiel Command.
Sampling. Administrators from each practice provided a 
list of patients with outpatient paper charts, sorted by phy-
sician and appointment date, who were seen for a new visit 
or well visit between May 1 and November 1, 2007. In order 
to draw from patients throughout the list, every third chart 
was reviewed, starting with the chart corresponding to a 
random digit provided by the Web site Random.org. At least 
25 patient charts were reviewed for each provider. A chart 
was excluded if the patient was younger than 18 years or if 
the entire chart was not located onsite. Paper charts were 
abstracted by 2 genetic counselors between December 2008 
and April 2010. Because 1 practice converted to an EMR sys-
tem in 2010, an additional list of patients with outpatient 
EMR charts was provided; 2 study coordinators and the proj-
ect director reviewed every other chart in this list in July and 
August of 2012. No identifying information was recorded, and 
standardized criteria for answering questions and interpret-
ing family health histories were applied to reduce interob-
server variability. Data quality was assessed by a genetics 
counselor who reviewed entries to correct errors. All data 
were analyzed in September 2012.
Statistical analysis. Abstracted data were entered into 
REDcap (Research Electronic Data Capture), a secure 
online survey and database storage tool. IBM SPSS Statistics 
software (version 19) was used for statistical analysis and 
reporting. Descriptive statistics were used to character-
ize the demographic characteristics of the patients and the 
health care providers and the characteristics of family health 
history collection.
To determine whether the family health history was infor-
mative enough to perform risk stratification and to alter a 
patient’s recommendations for prevention, this study used a 
set of quality indicators, which were subdivided by whether 
or not any of the patient’s family members were deceased. 
These quality indicators included: whether the family health 
history was updated during subsequent visits, whether a 
negative family health history was mentioned (eg, “no family 
health history of cancer”), whether the sex of affected rela-
tives was noted, whether the age of the affected relative at 
disease onset was noted, and whether the affected relative’s 
lineage was noted (ie, whether the affected relative was on 
the maternal or paternal side of the family). Two additional 
quality indicators were used to assess family health history 
when at least 1 relative had died: the cause of death and the 
deceased relative’s age at death. Because each quality indi-
cator is needed to perform an accurate risk assessment, fam-
ily health histories were deemed highly informative (of high 
quality) only when the chart contained all 5 quality indicators 
(if the chart made no mention of any relative being deceased) 
or all 7 quality indicators (if any relative was deceased).
Results
A total of 399 paper charts and 100 EMR charts were 
abstracted and entered into REDcap. Data from the paper 
charts were cleaned and corrected when necessary, result-
ing in the removal of 9 records.
Patient and Physician Characteristics
Physician characteristics are presented in Table 1, and 
patient characteristics are presented in Table 2. The median 
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patient age was 53 years. The most commonly noted dis-
eases were cardiovascular disease (CVD) and cancer. In per-
sonal disease histories, hypercholesterolemia was the most 
frequently mentioned type of CVD; it was noted in the charts 
of 180 (76.3%) of the 236 patients with CVD. Nonmelanoma 
skin cancer was the most commonly noted form of cancer; 
it was reported in 27 (55.1%) of the 49 patients with cancer. 
The average number of years a patient had been seen in the 
practice was 9.76 (±8.38) years, and the median length of 
time a patient had been seen in the practice was 8 years.
Family Health History Within Paper Charts
Location. More than 99% of paper charts contained some 
family health history data, which was scattered over several 
areas of the chart. In 306 of the 390 charts (78.5%), family 
health history was located in the physician’s notes. In 280 
(71.8%) of the charts, the family health history was found 
on the patient’s self-completed intake form; in 97 charts 
(24.9%), it was on the front summary page of the chart; in 
63 charts (16.2%) it was found in the consult notes; in 16 
charts (4.1%) it was found in a note from the patient; and 
in 1 (0.3%) of the charts, it was found in a nurse’s note. 
Frequently, family health history was noted separately in 
2 places. None of the examined charts contained a family 
health history in pedigree format.
Relatives assessed. When we looked at the health history 
of affected family members, we found that the health history 
of the patient’s parents was documented in 339 (86.9%) 
of 390 charts, while only about half as many charts 
(168 [43.1%]) contained the health history of siblings. Only 
131 charts (33.6%) contained the health history of grandpar-
ents; 67 charts (17.2%) contained the health history of aunts 
or uncles; and 32 charts (8.2%) contained the health history 
of children.
Diseases collected. A total of 390 charts were reviewed 
to assess whether the patient’s family health history men-
tioned either the presence of a disease (positive history) or 
the absence of a disease (negative history); we looked for 
diseases such as CVD, cancer, stroke, diabetes mellitus, 
arthritis, or depression. For example, more than three-quar-
ters of charts had a positive family history of CVD, whereas 
only 23.3% of the charts mentioned the absence of CVD in 
the family health history. Table 3 shows the diseases and 
conditions for which data were collected. Table 4 shows the 
number and proportion of charts that recorded each of the 
quality indicators mentioned previously; these quality indi-
cators are also discussed below.
Quality indicators. One quality indicator is whether the 
family health history has been updated. After an initial visit, 
the number of years before the first family health history 
was recorded in a patient’s chart ranged from 0 to 32 years, 
with a median of 0.0 and an interquartile range of 1.00. On 
average, the most recent family health history had been col-
lected or updated within the past 0.18 years (standard devia-
tion = 1.06). Of the 390 charts reviewed, 287 charts (73.6%) 
had been updated; 180 (62.7%) of the these charts had all 
updated changes, 53 (18.5%) of them had some updated 
changes, and 54 charts (18.8%) indicated that patients had 
been asked about updates but no changes had been made. 
table 1.
Characteristics of Providers Whose Patient 
Charts Were Reviewed (N = 16)
Characteristic Number of providers (%)
Sex
 Male 4 (25.0)
 Female 12 (75.0)
Years in practice
 ≤21 years 8 (50.0)
 >21 years 8 (50.0)
Medical specialty
 Family medicine 7 (43.8)
 Internal medicine 9 (56.3)
Race
 White 13 (81.3)
 Asian 2 (12.5)
 Hispanic 1 (6.3)
table 2.
Characteristics of Patients Whose Charts Were 
Reviewed (N = 390)
Characteristic Number of patients (%)
Sex
 Female 200 (51.3)
 Male 187 (47.9)
 Missing data 3 (0.8)
Race
 White 251 (64.3)
 African American 59 (15.1)
 Hispanic 4 (1.0)
 Asian 4 (1.0)
 Other 4 (1.0)
 Missing data 68 (17.6)
Type of insurance
 Commercial 269 (68.9)
 Medicare 54 (13.8)
 Medicaid  4 (1.0)
 Self-pay  1 (0.2)
 Unable to determine 55 (14.1)
 Missing data 7 (1.7)
Medical conditions
 Cardiovascular diseases 236 (60.5)
  Hypercholesterolemia 180 (46.1)
  Hypertension 157 (40.2)
  Other cardiovascular diseases 28 (7.1)
 Cancer 49 (12.5)
  Skin cancer 27 (6.9)
  Breast cancer 11 (2.8)
  Prostate cancer 6 (1.5)
  Other type of cancer 5 (1.2)
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Of the histories that were being taken for the first time, 37 
(66.1%) were for patients who were new to the practice.
Another quality indicator is whether a negative family 
health history is reported. Almost half (173 [44.4%]) of the 
charts explicitly recorded a generalized negative statement 
regarding family health history for a specific disease or dis-
ease group (eg, “family history negative for cancer”).
A third quality indicator is whether the sex of the affected 
relative is reported in the family health history. In 366 
(93.8%) of the charts, a positive family history of a specific 
disease or disease group was noted. In these charts, the sex 
of the affected relative was the most frequently collected 
quality indicator, having been specified in 356 (91.2%) of 
the charts reviewed. In some cases, the sex of the affected 
relative was known because of the words used to describe 
the relative (ie, aunt, uncle, mother, father, sister, brother). 
The sex of the affected relative was noted in 92% of the 
instances in which the relative was a parent, aunt, uncle, 
sibling, or grandparent. The sex of the affected relative was 
noted in only 3 (17.6%) of the instances in which the relative 
was a cousin and in only 6 (24.0%) of the instances in which 
the individual was described as a “relative.”
Age at disease onset for an affected relative was the 
least frequently collected quality indicator, having been col-
lected in only 71 (18.2%) of the 366 family health histories 
that recorded a positive family history. Specifically, age of 
disease onset was documented in family health histories 
for 11 (6.6%) of the siblings mentioned, 14 (10.8%) of the 
grandparents mentioned, 4 (6.3%) of the aunts or uncles 
mentioned, and 50 (14.8%) of the parents mentioned.
The fifth quality indicator for a family health history is 
whether the lineage of the affected relative is reported. Of 
the 366 family health histories that recorded a positive fam-
ily history, 255 (69.7%) did not include information about 
the lineage (ie, maternal or paternal side) of affected family 
members (Table 4). More than half of the 366 charts (233 
[63.7%]) did not mention an affected second-degree rela-
tive, and 44 charts did not mention an affected first-degree 
relative.
If the family health history includes mention of deceased 
relatives, then 2 additional quality indicators should be evalu-
ated: age at death and cause of death. A deceased relative was 
documented in 227 (62.0%) of the 366 records with a posi-
tive family health history. In 172 (75.8%) of those 227 records, 
the affected relative’s age at death was recorded, either for 
all deceased relatives (94/227 [41.4%]) or for some of them 
(78/227 [34.4%]). Of the 227 charts that noted a deceased 
relative, 213 (93.8%) listed the cause of death, either for all 
deceased relatives (165/227 [72.7%]) or for some of them 
(48/227 [21.1%]).
Quality of family health history. Less than 4% of patients 
had family health histories that could be used to perform a 
risk assessment. The group of 227 family health histories 
that mentioned a deceased relative included more “mod-
erately informative” histories and fewer “less informative” 
histories than did the group of family histories that did not 
include mention of any deceased relatives (Table 4). The 
number of quality indicators present in each group is shown 
in Table 4, and Table 5 shows the number of charts in which 
each of the first 5 quality indicators was reported. Among the 
charts that did not mention any deceased relative, 61 charts 
included 4 of the 5 quality indicators; the indicators that 
were most frequently absent were the age of the affected 
relative (missing in 28 [45.9%] of the charts), negative fam-
ily health history information (missing in 16 [26.2%] of the 
charts), and the lineage of the affected relative (missing in 
15 [24.6%] of the charts). Similar results were observed for 
the charts that mentioned one or more deceased relatives.
table 3.
Types of Family Health History Identified in Reviewed Chartsa (N = 390)
   Charts with positive FHH Charts with negative FHH 
Medical conditions of relatives Number of charts (%) Number of charts (%)
Cardiovascular diseases 338 (86.7) 91 (23.3)
 Hypertension 242 (62.0) 22 (5.6)
 Heart attack 150 (38.4) 10 (2.5)
 Hypercholesterolemia 69 (17.6) 4 (1.1)
Cancer 266 (68.2) 195 (50.0)
 Breast cancer 83 (21.2) 34 (8.8)
 Colon cancer 67 (17.2) 62 (15.9)
 Lung cancer 64 (16.4) 0 (0)
Stroke 71 (18.2) 4 (1.1)
Other conditions
 Diabetes 200 (51.2) 48 (12.4)
 Arthritis 71 (18.2) 14 (3.6)
 Depression 39 (10.0) 12 (3.1)
Note. FHH, family health history.
aTotals do not sum to the sample size because of missing data.
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table 4.
Characteristics of Reviewed Charts in Family Health History Project
   Charts with FHH  Charts with FHH 
   that do not mention  that do mention 
    deceased relatives deceased relatives 
  All charts (N = 390) (n = 163) (n = 277) 
Characteristic Number of charts (%) Number of charts (%) Number of charts (%)
FHH status
 Updated 287 (73.5) 92 (56.4) 186 (81.9)
 Not updated 91 (23.3) 49 (30.0) 38 (16.7)
 Missing data 12 (3.2) 22 (13.6) 3 (1.4)
Negative FHH
 Recorded 173 (44.3) 70 (42.9) 92 (40.5)
 Not recorded 213 (54.6) 71 (43.5) 135 (59.5)
 Missing data 4 (1.1) 22 (13.6) 0 (0)
Affected relativea
 Recorded 366 (93.8) 135 (82.8) 226 (99.6)
 Not recorded 24 (6.2) 6 (3.6) 1 (0.4)
 Missing data 0 (0) 22 (13.6) 0 (0)
Sex of affected relative 
 Recorded 356 (91.2) 129 (79.1) 222 (97.8)
 Not recorded 10 (2.5) 12 (7.3) 5 (2.2)
 Missing data 24 (6.3) 22 (13.6) 0 (0)
Affected relative’s age at disease onset
 Recorded 71 (18.2) 27 (16.5) 44 (19.3)
 Not recorded 256 (65.6) 108 (66.2) 182 (80.1)
 Missing data 63 (16.2) 28 (17.3) 1 (0.6)
Lineage of affected relative 
 Recorded 111 (28.4) 50 (30.6) 58 (25.6)
 Not recorded 255 (65.3) 91 (55.2) 169 (74.4)
 Missing data 24 (6.3) 22 (14.2) 0 (0)
Cause of death of affected relative
 Recorded NA NA 213 (93.8)
 Not recorded NA NA 14 (6.2)
Age of affected relative at death
 Recorded NA NA 172 (75.8)
 Not recorded NA NA 55 (24.2)
Number of quality indicators present
 0  2 (0.6) 2 (1.5) 0 (0)
 1 37 (10.2) 14 (10.4) 2 (0.9)
 2 119 (32.9) 41 (30.4) 6 (2.7)
 3 131 (36.2) 49 (36.3) 32 (14.3)
 4 61 (16.9) 26 (19.3) 86 (38.6)
 5 12 (3.3) 3 (2.2) 65 (29.1)
 6 NA NA 24 (10.8)
 7 NA NA 8 (3.6)
Quality of FHH
 Not informativeb 2 (0.6) 2 (1.5) 0 (0)
 Less informativec  156 (43.0) 55 (40.7) 40 (18.0)
 Moderately informatived  192 (53.1) 75 (55.6) 175 (78.4)
 Highly informativee  12 (3.3) 3 (2.2) 8 (3.6)
Note. FHH, family health history; NA, not applicable.
“Not recorded” means a characteristic was not asked about or was not checked in the chart; “missing data” means data is 
completely missing from the dataset.
aNot included as an indicator of quality.
bPedigrees were labeled “not informative” if they contained none of the quality indicators.
cPedigrees were labeled “less informative” if they did not mention any deceased relatives and contained 1–2 quality 
indicators, or if they did mention a deceased relative and contained 1–3 quality indicators.
dPedigrees were labeled “moderately informative” if they did not mention any deceased relatives and contained 3–4 quality 
indicators, or if they did mention a deceased relative and contained 4–6 quality indicators.
ePedigrees were labeled “highly informative” if they did not mention any deceased relatives and contained 5 quality 
indicators, or if they did mention a deceased relative and contained 7 quality indicators.
284 NCMJ vol. 74, no. 4
ncmedicaljournal.com
Family Health History Within EMRs
Out of 100 EMR charts, 97 (97%) documented some 
amount of family health history. No patient had a structured 
3-generation pedigree. Interestingly, the EMR’s family health 
history collection tool was not utilized for any of the charts 
we reviewed. In all cases, family health history was recorded 
in the free text section of the clinic note or on the patient 
intake form, and family health history was included for only 
a select few relatives.
Discussion
The inability to use family health histories in primary care 
poses a barrier to the practice of genomic medicine and 
limits physicians’ ability to achieve benchmarks set by pro-
grams such as Healthy People 2020 [37]. Several problems 
were encountered with the charts analyzed in this study, 
including a lack of uniformity in the collection methods, vari-
ations in the location within the chart where family health 
history information was reported, and missing information 
about essential elements of the family health history (as 
presented in Tables 4 and 5). Without all of these elements, 
an adequate risk assessment cannot be performed.
Family health histories that included information about 
deceased relatives were more likely to be “moderately infor-
mative” than were those without any mention of deceased 
relatives. The algorithm used to assess the quality of the fam-
ily health histories for the deceased-relative group included 
2 additional indicators (age at death and cause of death of the 
affected relative). More than two-thirds of the family health 
histories in the deceased-relative group recorded these 
2 indicators, thereby raising the mean quality of the family 
health histories and the quality of the information. It may be 
that when the death of an affected relative is recorded in a 
family health history, health care providers are more likely to 
seek details on the age at death and cause of death.
Although more than 97% of family health histories were 
updated, almost 23% contained incomplete information. 
Missing information included information that was previ-
ously collected but was not brought forward during subse-
quent visits and was thus lost. Some new EMR programs 
have addressed this problem.
In 80%–90% of the charts we reviewed, the age at diag-
nosis of an affected relative was never mentioned. Diagnosis 
of, or death from, a disease at an earlier age than expected 
can indicate a hereditary form of disease and is included 
in clinical algorithms to evaluate a patient’s disease risk 
 [13, 14, 19, 38]. Thus, there is a need for greater awareness 
about the importance of age at diagnosis for risk assess-
ment. Age at diagnosis is particularly important when 
using family health history to identify those most at risk for 
heart disease and cancer, the 2 leading causes of death in 
the United States [39]. Interestingly, using an EMR did not 
increase the amount or quality of information collected by 
the practitioner. Because EMRs presently do not prompt 
the physician to collect all of the elements necessary for an 
assessment of disease risk based on family health history, 
it remains uncertain whether family health histories will be 
fully utilized for these widespread diseases.
The family health histories of cancer documented in 
these charts resemble those found in other studies [5, 31]. 
The vast majority of patient charts had a documented posi-
tive family health history; in more than 45% of cases, how-
ever, diseases that were not found in the family (ie, negative 
family history) were not explicitly mentioned. If a negative 
family history was mentioned by a consulting physician, 
it typically was not updated in the primary care provider’s 
chart and was not considered when assessing the patient’s 
risk for disease. Documentation of a negative family health 
history is almost as important as documentation of a posi-
tive family health history, and primary care providers may 
benefit from greater awareness of its value for interpreting 
family health history data [34].
Several studies have estimated the chance of having an 
increased risk for disease on the basis of the family health 
history taken by the patient’s primary care provider [7, 8]. 
Based on the estimated frequency of at-risk patients seen 
in previous studies, we would have expected approximately 
180 individuals in this study to have a family health history 
that established a strong or moderate risk for breast and 
ovarian cancer or colon cancer, which would suggest the 
need for referral to a genetic specialist. However, no such 
referrals were made. Although patients were sometimes 
referred to a specialist, such as an oncologist or a gastroen-
terologist, charts rarely mentioned that a patient was at high 
risk for disease based on family health history; this is prob-
ably because such an evaluation would be time-consuming 
and difficult for the primary care provider, even if the fam-
ily health history were accurate and complete. Most charts 
had a patient intake form that allowed patients to self-report 
family health history. Several studies have found a bias for 
patients to overreport or underreport diseases, specifically 
cancer [40-42]. This may be another challenge to the effec-
tive utilization of family health history information.
table 5.
Number of Charts Containing Each Type of Quality 
Indicator, Cross-Tabulated with the Number of Quality 
Indicators Present in the Chart (Number of Charts = 390)
  Number of indicators present
Quality indicator 1 2 3 4 5
FHH status updated 3 91 112 59 12
Negative family history  
 recorded  2 20 82 45 12
Sex of affected relative  
 recorded 32 116 131 61 12
Affected relative’s age at  
 disease onset recorded 0 3 23 33 12
Lineage of affected relative  
 recorded 0 8 45 46 12
Note. FHH, family health history. 
Totals do not sum to the sample size because of missing data.
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Overcoming barriers to collection and use of family health 
histories in primary care. To remove several of the deficien-
cies we observed in the collection and interpretation of fam-
ily health histories, it would be helpful if clinicians had a tool 
that creates a structure containing all of the key elements 
of family health histories (eg, a pedigree), provides decision 
support for providers [5, 32, 43], and is compatible with 
EMRs. A family health history decision support tool would 
need to be able to do the following things: allow patients to 
fill out a form about their family health history using a secure 
online system prior to their appointment; update family 
health histories without dropping previously collected infor-
mation about family members; provide a single location for 
family health history within a chart (especially if the tool 
is compatible with the EMR); easily identify the number of 
affected and deceased family members; allow providers to 
quickly see whether a family has a negative disease his-
tory; and use clinically established information to provide an 
assessment of disease risk and recommendations regarding 
medical management.
Limitations
Limitations of this study that may reduce the generaliz-
ability of its findings to other populations include the small 
number of charts reviewed per primary care provider, the 
fact that the sample of primary care providers were all from 
a single geographic location, the failure to differentiate 
between patient-generated and physician-collected family 
health histories, and the inability to assess other quality indi-
cators, such as consanguinity. The latter limitation results 
from confusion about the information included in charts. For 
example, a chart might be unclear as to whether the number 
of family members in the family matches the number of rela-
tives mentioned in the family health history (eg, a patient 
might have 3 siblings, only 1 of whom is mentioned in the 
family health history), or there might be uncertainty about 
some pieces of information (eg, the family health history 
might mention a brother with heart disease and later refer 
to a brother with diabetes, without explaining whether these 
are 2 references to the same person or references to 2 dif-
ferent brothers). Another problem is that the chart review 
checklist does not collect certain additional types of infor-
mation (eg, consanguinity). Lastly, there is evidence in the 
literature that patient-provided family health histories can 
differ from physician-collected histories. Most charts con-
tained a patient intake form that had been used to collect 
family health history data, and this form was considered part 
of the family health history in the patient record. 
Despite these limitations, our findings are consistent 
with those of previous studies, suggesting common factors 
in the use of family health histories across multiple set-
tings. This study also did not allow for assessment of con-
versations between patients and providers; therefore, any 
information about family health history that was discussed 
in these conversations but was not mentioned in the clinic 
notes would not have been collected. The impact of ver-
bally communicated but undocumented family health his-
tory information is unknown but is important to consider, 
especially in primary care settings where relationships are 
often long-lasting and the time available for documentation 
is often limited.
Conclusion
Despite the value of family health histories for disease 
risk assessment, the histories collected in primary care prac-
tices usually lack some of the crucial information needed to 
perform a risk assessment for hereditary cancer syndromes 
and other chronic disorders [26]. If the use of family health 
histories for disease risk assessment is to succeed in pri-
mary care, collection must be easier and more complete. 
This study indicates a need for the adoption of family health 
history collection tools that can analyze the collected infor-
mation and provide risk-stratified decision support recom-
mendations.  
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